Clinical Trials
9 trialsNCT05578820 2024-07-01
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Gene Surgery LLC
Phase 1 Completed
NCT00093704 2020-07-31
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT00002824 2019-03-13
Gene Therapy in Treating Patients With Primary Brain Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00001328 2017-07-02
Gene Therapy for the Treatment of Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00005057 2015-04-29
Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00006216 2013-09-20
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00006340 2013-07-26
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Boston Medical Center
Phase 1 Completed
NCT00964756 2013-02-13
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
University of Alabama at Birmingham
Phase 1 Completed
NCT00006480 2010-09-21
Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Fred Hutchinson Cancer Center
Phase 1 Completed